Auto Shows Anti-Covid-19 vaccine: Moderna announces at least 100 million doses in the first quarter of 2021

Moderna plans to have between 100 and 125 million doses of its vaccine against Covid-19 available in the first quarter of the year 2021, the vast majority of which will go to the United States, the American biotechnology company said in a statement on Thursday.

In detail, it is between 85 and 100 million of these doses that will be reserved in the United States, and between 15 to 25 million to the rest of the world, she said. She also reaffirmed that 20 million doses would be available for the United States before the end of the year.

READ ALSO> The anti-Covid vaccine available in the United Kingdom "next week": why such an advance?

The 12 Cheapest Cars With 300 Horsepower, 2020 Edition

Few things in life are as thrilling as cheap speed.But if you think 300 horsepower equals driving excitement, well, think again. Some of these cars are far better suited to grocery store runs than they are track days. Still, with even the most expensive car on this list ringing in at under $38,000, that's something to celebrate. If you're looking for even more horsepower, don't miss our breakdowns of the most affordable cars with 400-plus-horsepower and the 500-plus-horsepower kings and queens of the road.

(Reuters) - Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its COVID - 19 vaccine available globally in the first quarter of 2021 . The company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25

About mRNA-1273, Moderna 's Vaccine Candidate Against COVID - 19 . March 16: Moderna Announces First Participant Dosed in As has previously been disclosed, the ability of the Company to make millions of doses per month is contingent on investments in the scale up and further

Moderna, whose vaccine provides at least three months of immunity according to a study, has been preparing the supply chain with the US government for months to be ready as soon as the US Drug Agency (FDA) has authorized the vaccine. For all countries outside the United States, production will be carried out in Switzerland, in the factories of the Lonza group.

Clearance by end of month

US officials have said they plan to distribute 40 million doses in all by the end of the year in the country, also including those produced by the US-German alliance Pfizer / BioNTech. That is 20 million people vaccinated by the end of 2020, since the vaccine is administered in two doses.

Moderna has applied for clearance with the FDA, and the agency's advisory committee, which is reviewing the full clinical trial data, will meet on December 17, with clearance normally expected shortly thereafter. The FDA meeting for Pfizer / BioNtech's vaccine, which was cleared on Wednesday in the UK, will take place on December 10.